Impact of matrix-associated soluble factors on the specificity of the immunogenicity assessment

Bioanalysis

Volumn 2, Issue 4, 2010, Pages 721-731

  Bautista, Ami C ^a   Wullner, Danika ^a   Moxness, Mike ^a   Swanson, Steven J ^a   Chirmule, Narendra ^a   Jawa, Vibha ^a  

^a AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; DRUG ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; RHEUMATOID FACTOR; ANTIBODY; DRUG; LIGAND;

ARTICLE; BIOLOGICAL THERAPY; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL; HUMAN; IMMUNE RESPONSE; IMMUNOGENICITY; LIGAND BINDING; REAL TIME SURFACE PLASMON RESONANCE; RHEUMATOID ARTHRITIS; SENSITIVITY AND SPECIFICITY; SURFACE PLASMON RESONANCE; ANALYSIS; ARTIFACT; BIOASSAY; BLOOD; DRUG EFFECT; IMMUNITY; IMMUNOASSAY; IMMUNOLOGY; METABOLISM; METHODOLOGY; SOLUBILITY;

ANALYTIC SAMPLE PREPARATION METHODS; ANTIBODIES; ARTIFACTS; BIOLOGICAL ASSAY; HUMANS; IMMUNITY; IMMUNOASSAY; LIGANDS; PHARMACEUTICAL PREPARATIONS; SOLUBILITY;

EID: 79952459124     PISSN: 17576180     EISSN: 17576199     Source Type: Journal    
DOI: 10.4155/bio.10.24     Document Type: Article

References (19)

1. Bourdage J, Cook C, Farrington D, Chain J, Konrad R. An affinity capture elution (ace) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug. J. Immunol. Method. 327, 10-17 (2007). (Pubitemid 47444307)
2. Lofgren J, Dhandapani S, Pennucci J et al. Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab. J. Immunol. 178, 7467-7472 (2007). (Pubitemid 46847475)
3. Moxness M, Tatarewicz S, Weerarante D et al. Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapuetic human monoclonal antibodies. Clin. Chem. 51, 1983-1985 (2005). (Pubitemid 41368199)
4. Patton A, Mullenix M, Swanson S, Koren E. An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen. J. Immunol. Method. 304, 189-195 (2005). (Pubitemid 41262233)
5. Sickert D, Kroeger K, Zickler C et al. Improvement of drug tolerance in immunogenicity testing by acid treatment on biacore. J. Immunol. Method. 334, 29-36 (2008).
6. Swanson S, Chirmule N. Assessing specificity for immunogenicity assays. Bioanalysis 1(3), 611-617 (2009).
7. Jones A, Honour J. Unusual results from immunoassays and the role of the clinical endocrinologist. Clin. Endocrinol. 64(3), 234-244 (2006).
8. Ritter G, Cohen L, Williams C Jr, Richards E, Old L, Welt S. Serological analysis of human anti-human antibody responses in colon cancer patients treated with repeated doses of humanized monoclonal antibody a33. Cancer Res. 61, 6851-6859 (2001). (Pubitemid 32896510)
9. Zhong ZD, Dinnogen S, Hokom M et al. Identification and inhibition of drug target interference in immunogenicity assays. J. Immunol. Methods DOI: 10.1016/j. jim.2010.02.008 (2010) (Epub ahead of print).
10. Mire-Sluis A, Barrett Y, Devanarayan V et al. Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products. J. Immunol. Method. 289(1-2), 1-16 (2004). (Pubitemid 38900899)
11. Chamberlain P, Mire-Sluis A. An overview of scientific and regulatory issues for the immunogenicity of biological products. Dev. Biol. 112, 3-11 (2003).
12. Koren E, Zuckerman L, Mire-Sluis A. Immune responses to therapeutic proteins in humans - clinical significance, assessment and prediction. Curr. Pharm. Biotechnol. 3(4), 349-360 (2002). (Pubitemid 35364009)
13. Mason S, La S, Mytych D, Swanson S, Ferbas J. Validation of the Biacore 3000 platform for detection of antibodies against erythropoietic agents in human serum samples. Curr. Med. Res. Opin. 19(7), 651-659 (2003). (Pubitemid 37288073)
14. Harlow E, Lane D. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory, NY, USA, 298-299 (1988).
15. Koren E, Smith H, Shores E et al. Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products. J. Immunol. Method. 333(1-2), 1-9 (2008).
16. Nadar A, Gupta S, Kaliyaperumal A, Swanson S. Validation of a cell based assay to detect anti-drug neutralizing antibodies in cynomolgus monkey serum pretreated with pierce Melon Gel. AAPS (2005).
17. Cemalettin A, Turgut I. Development of a rapid, single-step procedure using protein g affinity chromatography to deplete fetal calf serum of its IgG1 and to isolate murine IgG1 monoclonal antibodies from supernatants of hybridoma cells. J. Immunol. Method. 233, 77-81 (2000).
18. Echan L, Tang H, Ali-Khan N, Lee K, Speicher D. Depletion of multiple high-abundance proteins improves protein profiling capacities of human serum and plasma. Proteomics 5(13), 3292-3303 (2005). (Pubitemid 41192036)
19. Butch A. Dilution protocols for detection of hook effects/ prozone phenomenon. Clin. Chem. 46, 1719-1720 (2000).